Stockreport

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence [Yahoo! Finance]

Allurion Technologies, Inc.  (ALUR) 
PDF NATICK, Mass., March 20, 2025 BUSINESS WIRE )--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today anno [Read more]